NewGenIvf Group Limited (NIVF) is a prominent provider in the reproductive health sector, specializing in advanced fertility solutions and innovative in vitro fertilization (IVF) services. The company is dedicated to enhancing success rates in assisted reproductive techniques and addresses the growing global demand for fertility treatments through a well-established network of clinics and strategic partnerships. Positioned for growth within a rapidly expanding market, NIVF is well-equipped to capitalize on emerging opportunities, reinforcing its commitment to helping individuals and couples realize their dreams of parenthood.
| Revenue (TTM) | $4.73M |
| Gross Profit (TTM) | 955,850 |
| EBITDA | $-10.54M |
| Operating Margin | -349.10% |
| Return on Equity | 79.40% |
| Return on Assets | -36.90% |
| Revenue/Share (TTM) | $102.73 |
| Book Value | $818.78 |
| Price-to-Book | 0.04 |
| Price-to-Sales (TTM) | 0.26 |
| EV/Revenue | 1.114 |
| EV/EBITDA | 0.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.90% |
| Shares Outstanding | 568,470 |
| Float | 568,470 |
| % Insiders | 0.04% |
| % Institutions | 0.46% |